📰 Poolbeg Pharma Plc News
Poolbeg Pharma Plc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Poolbeg Pharma Plc. Real-time updates on events, politics, business and more.
May 1, 2024
Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in ...
April 30, 2024
Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug ...
April 30, 2024
Investegate announcements from Appointment of Joint Broker
February 22, 2024
Director Share PurchaseLONDON, UK / ACCESSWIRE / February 22, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that it has rece...
February 15, 2024
LONDON, UK / ACCESSWIRE / February 15, 2024 / Poolbeg Pharma (AIM:POLB, OTCQB:POLBF, "Poolbeg" or the "Company"), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces a change of Board ro...
January 26, 2024
Learn about Poolbeg Pharma Plc's strategic shift towards sustainable revenue and profitability in this Investor Presentation by CEO Jeremy Skillington. Discover their focus on developing innovative medicines for unmet medical needs and their strong financial position. Find out more.
November 21, 2023
Poolbeg Pharma Immunomodulator II patent granted in Japan
November 21, 2023
Immunomodulator II patent granted in Japan
November 9, 2023
Poolbeg Pharma Appoints Senior Members of Former Amryt Pharma Leadership Team
November 3, 2023
Poolbeg Pharma POLB 001 Data to be Presented at American Society of Hematology Annual Meeting